The Myeloma Institute

The UAMS Myeloma Institute, under the leadership of Dr. Gareth Morgan, is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulemia Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Institute is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.

We are committed to

  • Accelerating curative therapies for multiple myeloma and related diseases through an integrated program of innovative research and high-quality, comprehensive patient care
  • Customizing care based on each patient’s genetic profile and risk factors for truly personalized treatment
  • Pushing the envelope of understanding and discovery to unravel the biology of multiple myeloma and maximize cure

Full Article

What is multiple myeloma?

What is Multiple Myeloma?

Learn about multiple myeloma biology, symptoms, diagnosis and more.

Learn more

morgan-myeloma-team

Why Choose the Myeloma Institute

Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates.

Learn More

myeloma genome presentations

ASH 2016 Poster Presentations

The ASH annual meeting attracts more than 20,000 hematology professionals from more than 100 countries

View Presentations

Myeloma Magazine 2016

Myeloma Magazine – Fall 2016

As you will learn in this issue of Myeloma, a collaborative international study has revealed gene variants that increase the risk of developing myeloma.  Read Digital Issue